Arkema Closes Acquisition of 54% Stake in PI Advanced Materials

On Dec. 1, 2023, French chemicals and materials company Arkema has finalized the acquisition of Glenwood Private Equity’s 54% – based on a €728 million enterprise value – stake in South Korean company PI Advanced Materials (PIAM). Arkema said in a statement that this acquisition acquisition – first announced last June – complements its portfolio of high-performance technologies for the high-growth markets of advanced electronics and electric mobility.

With more than 30% market share, PIAM, headquartered in Seoul, is the global leader of polyimide films used in the high-growth and high value-added markets of mobile devices and electric vehicles.

According to Arkema, PIAM sales are expected to grow by around 13% per year in the coming years, driven by new cutting-edge applications in 5G antennas, high-resolution OLED displays, flexible screens and electric vehicles, and supported by recent capacity expansions.

Arkema said that PIAM's portfolio, which will strengthen its own range of high-performance polymers, combined with the perfect geographic fit with the group, should enable the French group to achieve synergies estimated at €30 million in terms of EBITDA over the next five years.

© 2016 bluebay/Shutterstock
© 2016 bluebay/Shutterstock

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.